Protocol Ledger

NCT06196320 · Phase III · COMPLETED

Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events-5

Interventional Phase III clinical trial protocol NCT06196320 sponsored by Beijing Tiantan Hospital in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-01-24 Enrollment: 452 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT06196320
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)452 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)1 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06196320
Protocol FieldVerified Registry Value
NCT IdentifierNCT06196320
Consolidated Lead SponsorBeijing Tiantan Hospital
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase III
Overall Recruitment StatusCOMPLETED
Registered Enrollment452 participants (ACTUAL)
Registered Start Date2024-01-24
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT06196320
Hospital Research SiteLocationSite Profile
Affiliated Hospital of Hebei UniversityBaoding, ChinaOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI